The global generic Injectables market was estimated an 11.6% compound annual growth rate (CAGR) of during the forecast period 2019–2025.

Some of the key players in the market are Pfizer, Novartis AG, Sanofi SA, Cipla, Samsung Biologics, AstraZeneca plc, Mylan NV, Dr. Reddys Laboratories, Merck & Co. Inc. and Others

Rising patent drug expiry to boost the global generic injectables Market

The increasing patents of branded drugs are expected to expire in the near future, and this is driving the market growth of generic injectables. Some of the major patent expirations in 2017 are Alimta, Norditropin, Eloxatin, and Remodulin. These patent expirations will demand effective generic injectables to overcome drug shortage and issues like patent expiry, further fueling market growth.

The global generic injectables market is bifurcated on the basis of Drug Delivery System Type: Orals, Injectables, Dermal/Topical, Inhalers. Based on Therapeutic Areas: Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular Diseases. On the basis of Containers: Vials, Ampoules, Premix, Prefilled Syringes and Based on Distribution Channel: Hospital Pharmacy and Retail Pharmacy

The Asia Pacific Region Expected to Witness fastest Growth in the Global Generic Injectables Market

Based on geographical analysis, the global generic injectables market is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The growth of the generic injectables market across Asia Pacific is due to the presence of a higher pool of patients suffering from various diseases that require generic drugs, patent expiration of many drugs in the future, shortage of drugs. Furthermore, the surge in healthcare expenditure and new technological advancements will propel the growth of the industry in the region. In addition to this, government initiatives focused on the treatment and R&D spends in this region will boost the growth of the market.

Request For Sample of this Report: click here

The global generic injectables market is segmented as follows:

By Drug Delivery System Type:

  • -Orals
  • -Injectables
  • -Dermal/Topical
  • -Inhalers

By Therapeutic Areas:

  • -Oncology
  • -Anaesthesia
  • -Anti-Infectives
  • -Parenteral Nutrition
  • -Cardiovascular Diseases

By Containers:

  • -Vials
  • -Ampoules
  • -Premix
  • -Prefilled Syringes

By Distribution Channel:

  • -Hospital Pharmacy
  • -Retail Pharmacy

By region:

  • North America
    • -The U.S.
    • -Canada
  • Europe
    • -France
    • -The UK
    • -Spain
    • -Germany
    • -Italy
    • -Rest of Europe
  • Asia Pacific
    • -China
    • -Japan
    • -India
    • -South Korea
    • -Southeast Asia
    • -Rest of Asia Pacific
  • Latin America
    • -Brazil
    • -Mexico
    • -Rest of Latin America
  • Middle East & Africa
    • -GCC
    • -South Africa
    • -Rest of Middle East & Africa

About Us:

FAST.MR is a global market research and business-consulting organization that aims to provide a deep market insight to our clients, which helps them in better decision making in the dynamic environment. We have a team of highly qualified personnel that studies the market in-depth to provide our clients with better strategies to stand out in the market.

Our report covers the current market status, opportunities available in the market, growth plans, and emerging trends in order to cater to the evolving needs of the customers. We help businesses around the globe with operational improvements, technologies, emerging market trends that in-depth boost the company’s growth in the future. The reports prepared by us are customized according to the client’s needs. We inculcate high morale and ethics while preparing our report which helps in building long-term relationships with our clients.

Contact Us:
Fast.MR
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: [email protected]
Website: www.fastmr.com

Request For Customization



Request Customization

Check Discount



Request Discount